GRI Bio, Inc. - Common Stock (GRI)
2.8800
+0.5900 (25.76%)
NASDAQ· Last Trade: Sep 5th, 8:37 AM EDT
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Via Stocktwits · January 28, 2026
Via Benzinga · November 20, 2025
Via Benzinga · September 22, 2025
Via Benzinga · September 12, 2025
Via Benzinga · September 12, 2025
Via Benzinga · September 11, 2025
Via Benzinga · September 11, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 22, 2025
GRI Bio reported interim Phase 2a results for GRI-0621 in IPF, showing safety and no significant cholesterol changes.
Via Benzinga · April 1, 2025

Via Benzinga · November 15, 2024

Via Benzinga · November 1, 2024

Via Benzinga · October 23, 2024

Via Benzinga · October 22, 2024

Via Benzinga · October 22, 2024

Via Benzinga · October 22, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 18, 2024

Via Benzinga · October 14, 2024
